OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cells

Molecular Pharmacology
Margaret A ParkPaul Dent

Abstract

We have further defined mechanism(s) by which 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}acetamide [OSU-03012 (OSU)], a derivative of the cyclooxygenase-2 (COX2) inhibitor celecoxib but lacking COX2 inhibitory activity, kills transformed cells. In cells lacking expression of protein kinase R-like endoplasmic reticulum kinase (PERK(-/-)), the lethality of OSU was attenuated. OSU enhanced the expression of Beclin 1 and ATG5 and cleavage of pro-caspase 4 in a PERK-dependent fashion and promoted the Beclin 1- and ATG5-dependent formation of vacuoles containing LC3, followed by a subsequent caspase 4-dependent cleavage of cathepsin B and a cathepsin B-dependent formation of low pH intracellular vesicles; cathepsin B was activated and released into the cytosol and genetic suppression of caspase 4, cathepsin B, or apoptosis-inducing factor function significantly suppressed cell killing. In parallel, OSU caused PERK-dependent increases in 70-kDa heat shock protein (HSP70) expression and decreases in 90-kDa heat shock protein (HSP90) and Grp78/BiP expression. Changes in HSP70 expression were post-transcriptional. Knock-down or small-molecule inhibition of HSP70 expression enhanced OSU toxicity, and ove...Continue Reading

References

Feb 15, 1992·Experientia·P O Seglen, P Bohley
Dec 1, 1999·Cell Death and Differentiation·P G EkertD L Vaux
Sep 13, 2000·Molecular and Cellular Biology·D D MosserB Massie
Nov 14, 2000·The Journal of Biological Chemistry·V StokaG S Salvesen
Sep 5, 2001·Nature Cell Biology·L RavagnanG Kroemer
Nov 20, 2002·The Journal of Clinical Investigation·David Ron
Aug 30, 2003·Oncogene·Paul DentSteven Grant
Jan 20, 2004·Trends in Cell Biology·D Thomas Rutkowski, Randal J Kaufman
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven Grant, Paul Dent
May 5, 2004·The Journal of Cell Biology·Junichi HitomiMasaya Tohyama
Jul 16, 2004·Seminars in Oncology·Claus-Henning Koehne, Raymond N Dubois
Aug 4, 2004·Cancer Research·Nicole FehrenbacherMarja Jäättelä
Aug 18, 2004·The Journal of Experimental Medicine·Jesper NylandstedMarja Jäättelä
Dec 8, 2004·Current Medicinal Chemistry·W Kiefer, G Dannhardt
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Manish I PatelAndrew J Dannenberg
Apr 5, 2005·Methods : a Companion to Methods in Enzymology·Amy S Lee
Jul 27, 2005·Biochemical Society Transactions·K Kashfi, B Rigas
Oct 4, 2005·The Journal of Clinical Investigation·Beth Levine, Junying Yuan
Oct 13, 2005·Current Opinion in Gastroenterology·Christopher J Hawkey, Paul J Fortun
Nov 22, 2005·Acta Pharmacologica Sinica·Ya-Ping YangZheng-Hong Qin
Nov 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wei CuiKe-Qin Hu
Mar 9, 2006·The Journal of Biological Chemistry·Mamoru ShibataJunying Yuan
Sep 26, 2006·Nature Cell Biology·Shida YousefiHans-Uwe Simon
Nov 23, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Salamatu S Mambula, Stuart K Calderwood
Dec 19, 2006·The Journal of Biological Chemistry·Lori S HartConstantinos Koumenis
Mar 17, 2007·Molecular Cancer Therapeutics·Kristoffer ValeriePaul Dent
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuhong ZhangSherif S Farag

❮ Previous
Next ❯

Citations

Mar 26, 2010·Journal of Medicinal Chemistry·Christopher G EvansJason E Gestwicki
Jan 6, 2012·Molecular Pharmacology·Yong TangPaul Dent
Oct 7, 2009·Antimicrobial Agents and Chemotherapy·Hao-Chieh ChiuChing-Shih Chen
Apr 12, 2012·Molecular Cancer Therapeutics·Neil E BholaJennifer R Grandis
Dec 30, 2014·Journal of Cellular Physiology·Laurence BoothPaul Dent
Oct 11, 2014·Journal of Cellular Physiology·Laurence BoothPaul Dent
Dec 3, 2014·International Journal of Pharmaceutics·Ky V HoangKristy M Ainslie
Feb 26, 2015·Autophagy·Karol DokladnyPope L Moseley
Sep 22, 2010·Cancer Biology & Therapy·Clint MitchellPaul Dent
Sep 20, 2012·Cancer Biology & Therapy·Laurence BoothPaul Dent
Feb 18, 2015·DNA and Cell Biology·Laurence BoothPaul Dent
Jul 4, 2017·Cells·Eunice Domínguez-MartínRicardo Escalante
Sep 18, 2008·International Journal of Cancer. Journal International Du Cancer·Haiming DingSteven M D'Ambrosio
Jul 19, 2011·Oncogene·W K K WuJ J Y Sung
Apr 12, 2013·The Journal of Biological Chemistry·Karol DokladnyPope Lloyd Moseley
May 24, 2016·Oncotarget·Andrew PoklepovicPaul Dent
Oct 2, 2016·Journal of Fungi·Kaila M Pianalto, J Andrew Alspaugh
Aug 9, 2019·Current Topics in Medicinal Chemistry·Bingqian YanWei Fu
May 22, 2019·Current Topics in Medicinal Chemistry·Guangyu ZhangZhao V Wang
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Guo ZhangPaul Dent
Aug 12, 2014·Molecular Cancer Therapeutics·Laurence BoothPaul Dent
May 17, 2019·Current Opinion in Pharmacology·Dalia H AbdelazizHermann M Schatzl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.